Evaluation of the efficacy and safety of oral N‐acetylcysteine in patients with COVID‐19 receiving the routine antiviral and hydroxychloroquine protocol: A randomized controlled clinical trial

Evaluation of the efficacy and safety of oral N‐acetylcysteine in patients with COVID‐19 receiving the routine antiviral and hydroxychloroquine protocol: A randomized controlled clinical trial

Abstract Background The current absence of gold‐standard or all‐aspect favorable therapies for COVID‐19 renders a focus on multipotential drugs proposed to prevent or treat this infection or ameliorate its signs and symptoms vitally important. The present well‐designed randomized controlled trial (R...

Full description

Bibliographic Details
Main Authors: Najmolsadat Atefi, Azadeh Goodarzi, Taghi Riahi, Niloofar Khodabandehloo, Mahshid Talebi Taher, Niloufar Najar Nobari, Farnoosh Seirafianpour, Zeinab Mahdi, Amir Baghestani, Rohollah Valizadeh
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:Immunity, Inflammation and Disease
Subjects:
antiviral
atazanavir
COVID‐19
hydroxychloroquine
Kaletra
lopinavir
Online Access:https://doi.org/10.1002/iid3.1083

Internet

https://doi.org/10.1002/iid3.1083

Similar Items